Portrait of Devin Oller
ucsf logo

Devin Oller, MD

Internal Medicine
General Internal Medicine Mount Zion – 1600 Divisadero St.
415-353-7900
Portrait of Devin Oller
Portrait of Devin Oller
ucsf logo

Devin Oller, MD

Internal Medicine
General Internal Medicine Mount Zion – 1600 Divisadero St.
415-353-7900

On this page

About me

Dr. Devin Oller is a primary care doctor who champions and advocates for his patients while providing the latest treatments. He has a special interest in caring for patients living with complex chronic diseases, pain or addiction.

Oller's research focuses on developing interventions that can help communities improve the lives of people with addiction.

Oller earned his medical degree from the Lewis Katz School of Medicine at Temple University. He completed a residency in internal medicine at Massachusetts General Hospital, where he served as chief resident. He also completed a fellowship in rural health leader at the Indian Health Service at Rosebud, South Dakota.

Oller grew up in the Bay Area but has lived in all four U.S. commonwealths: Virginia, Pennsylvania, Massachusetts and Kentucky.

Education & training

Board certification

  • Addiction Medicine, American Board of Preventive Medicine
  • Internal Medicine, American Board of Internal Medicine

Fellowship

  • Internal Medicine, Massachusetts General Hospital GME
  • Rural Health Leadership, Massachusetts General Hospital GME

Residency

  • Internal Medicine, Massachusetts General Hospital GME
  • Internal Medicine, University of California Davis Health System - GME

Degree

  • MD, Temple University School of Medicine

My expertise

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.